Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neisseria meningitidis capsular polysaccharides (serogroup W-135) (None)
- Target
- None
- Molecular classification
- Polysaccharide, Capsular Polysaccharide, Antigen
01
Overview
Neisseria meningitidis group W-135 capsular polysaccharide is a surface-expressed carbohydrate polymer crucial for bacterial survival during infection due to its role in immune evasion. It serves as both an epidemiological marker distinguishing this important pathogenic group and as an effective target antigen for current multivalent conjugate vaccines designed to prevent life-threatening infections caused by this organism.
- Other names
- N. meningitidis serogroup W-135 capsular polysaccharideGroup W-135 capsular polysaccharideW-135 CPS
02
Mechanism of action
Antibody-mediated complement activation; Opsonization; Induction of protective immunity
03
Biological functions
Immune evasionBacterial virulenceCapsule formationAntigen presentation
04
Disease associations
MeningitisSepticemiaInvasive meningococcal diseaseInfection
05
Safety considerations
Hypersensitivity reactions to vaccine componentsInjection site reactions
06
Interacting drugs
Menactra
2 more in the full profile.
Beyond the preview
Go deeper on Neisseria meningitidis capsular polysaccharides (serogroup W-135) (None).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neisseria meningitidis capsular polysaccharides (serogroup W-135) (None).